Bayesian Capital Management’s Maximus MMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,469
Closed -$226K 379
2025
Q3
$226K Buy
+2,469
New +$200K 0.05% 441
2024
Q2
Sell
-6,105
Closed -$512K 957
2024
Q1
$512K Buy
+6,105
New +$502K 0.05% 431
2023
Q4
Sell
-5,768
Closed -$431K 926
2023
Q3
$431K Buy
+5,768
New +$470K 0.05% 400
2023
Q1
Sell
-5,155
Closed -$378K 981
2022
Q4
$378K Buy
+5,155
New +$333K 0.06% 422
2020
Q1
Sell
-8,900
Closed -$662K 902
2019
Q4
$662K Buy
8,900
+1,900
+27% +$143K 0.11% 242
2019
Q3
$541K Buy
+7,000
New +$531K 0.1% 260
2017
Q3
Sell
-8,400
Closed -$526K 588
2017
Q2
$526K Buy
+8,400
New +$521K 0.19% 177
2017
Q1
Sell
-11,718
Closed -$654K 598
2016
Q4
$654K Buy
+11,718
New +$637K 0.16% 238

Other funds holding MMS

Bayesian Capital Management's MMS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Maximus (MMS) in Q4 2025, closing a stake of 2,469 shares — an estimated $226K sold.

Bayesian Capital Management first reported a position in MMS in Q4 2016 and held it in 8 quarters. The position peaked at $662K in Q4 2019. 386 funds tracked by Wall St. Rank hold MMS as of Q4 2025.

  • Bayesian Capital Management reported no remaining Maximus position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,469 Maximus shares in Q4 2025, an estimated $226K.
  • Bayesian Capital Management first reported a position in Maximus in Q4 2016 and held it in 8 quarters.
  • Bayesian Capital Management's Maximus position peaked at $662K in Q4 2019.
  • 386 funds tracked by Wall St. Rank held Maximus as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.